KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Decroos A, Cheminant M, Bruneau J, Carras S, Parinet V, Pelletier L, Lacroix L, Martin N, Giustiniani J, Lhermitte L, Asnafi V, Battistella M, Lemonnier F, De Leval L, Sicard H, Bonnafous C, Gauthier L, Genestier L, Caruso S, Gaulard P, Hermine O, Ortonne N.
Decroos A, et al.
Haematologica. 2023 Oct 1;108(10):2830-2836. doi: 10.3324/haematol.2022.282220.
Haematologica. 2023.
PMID: 37165836
Free PMC article.
No abstract available.